长风药业(02652.HK)董事会通过H股回购授权议案
CF PHARMTECHCF PHARMTECH(HK:02652) Ge Long Hui·2025-11-12 23:10

Core Viewpoint - Changfeng Pharmaceutical (02652.HK) has announced that its board of directors has approved a proposal to grant a general mandate for the repurchase of the company's issued H shares listed on the Hong Kong Stock Exchange, which will be presented for consideration and approval at a forthcoming special general meeting of shareholders [1] Group 1 - The board's resolution includes a proposal for a share buyback authorization [1] - The proposal will be submitted to shareholders for approval at a special general meeting [1]